Ipilimumab
17G.508
Phase 1 mab terminated
Quick answer
Ipilimumab for Stage III Prostate Cancer is a Phase 1 program (mab) at REGENERON PHARMACEUTICALS, INC. with 1 ClinicalTrials.gov record(s).
Program details
- Company
- REGENERON PHARMACEUTICALS, INC.
- Indication
- Stage III Prostate Cancer
- Phase
- Phase 1
- Modality
- mab
- Status
- terminated